VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300
eLife · 2025
DOI: 10.7554/elife.98386 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Susu Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Oncogene Proteins, Fusion, Carcinogenesis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Natural Science Foundation of China, NIH HHS.
Abstract (Originalsprache)
Studies on Hippo pathway regulation of tumorigenesis largely center on YAP and TAZ, the transcriptional co-regulators of TEADs. Here, we present an oncogenic mechanism involving VGLL and TEAD fusions that is Hippo pathway-related but YAP/TAZ-independent. We characterize two recurrent fusions, VGLL2-NCOA2 and TEAD1-NCOA2 , recently identified in human spindle cell rhabdomyosarcoma. We demonstrate that in contrast to VGLL2 and TEAD1 the fusion proteins are potent activators of TEAD-dependent transcription, and the function of these fusion proteins does not require YAP/TAZ. Furthermore, we identify that VGLL2 and TEAD1 fusions engage specific epigenetic regulation by recruiting histone acetyltransferase EP300 to control TEAD-mediated transcriptional and epigenetic landscapes. We show that small-molecule EP300 inhibition can suppress fusion protein-induced oncogenic transformation both in vitro and in vivo in mouse models. Overall, our study reveals a molecular basis for VGLL involvement in cancer and provides a framework for targeting tumors carrying VGLL , TEAD , or NCOA translocations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, United States.
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, United States.
- Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States.
ORCID-Profile: Susu Guo, Jennifer L Cotton, Y Tony Ip, Jiayi Wang, Junhao Mao
Förderung
- NIDDK NIH HHS
- National Natural Science Foundation of China
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Guo, S., Hu, X., Cotton, J. L., Ma, L., Li, Q., Cui, J., Wang, Y., Thakare, R. P., Tao, Z., Ip, Y. T., Wu, X., Wang, J., & Mao, J. (2025). VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. eLife. https://doi.org/10.7554/elife.98386
Vancouver
Guo S, Hu X, Cotton JL, Ma L, Li Q, Cui J, et al. VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. eLife. 2025. doi:10.7554/elife.98386
BibTeX
@article{Guo2025,
author = {Guo, Susu and Hu, Xiaodi and Cotton, Jennifer L and Ma, Lifang and Li, Qi and Cui, Jiangtao and Wang, Yongjie and Thakare, Ritesh P and Tao, Zhipeng and Ip, Y Tony and Wu, Xu and Wang, Jiayi and Mao, Junhao},
title = {VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.98386}
}
EUVIMED